Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Jefferies downgrades Tate & Lyle following strong share performance as NAFTA issues loom

Analysts said potential fallout from the US/Canada spat and potential NAFTA renegotiation weighed on its estimates in addition to a return to normality following a share price surge
Tate & Lyle logo
Despite the downgrade, analysts upped the group's target price to 700p from 665p

US broker Jefferies has downgraded Tate & Lyle PLC (LON:TATE) to ‘Hold’ from ‘Buy’ as its valuation returned to normal ranges following a strong share price performance as well as concerns around NAFTA.

Analysts at the broker said the FTSE 250 ingredients business had seen fresh impetus and strategic clarity from its full-year results in May, but added that a guide of lower profits from Tate & Lyle’s peer Ingredion Inc. (NYSE:INGR) for the current year struck a cautionary note that led to a downgrade of its forecasts.

READ: Tate & Lyle downgraded by Kepler Cheuvreux as it questions ability to beat ‘peak’ 2017/18

Jefferies was also concerned about the future of the North American Free Trade Agreement (NAFTA) and its potential impact on Tate & Lyle’s bottom line: “The optimism of late April seems to have evaporated as NAFTA becomes collateral damage in a wider trade war and US/Canada spat. There is a possibility that this might open the way for a bilateral agreement with Mexico, in which context we were intrigued by Mexico's decision not to include HFCS [High-fructose Corn Syrup] in its recent retaliatory tariffs. But the US$: peso continues to discount gloom.”

Despite the downgrade, analysts upped the group's target price to 700p from 665p, but also highlighted the firm’s outperformance against Ingredion as a key reason behind the downgrade, saying that the outperformance in the shares had taken it to parity with Ingredion and thus “evaporated” a key plank of its Buy thesis.

Jefferies said: “New CEO Hampton had made his mark with fresh clarity on strategy and decisive action on costs. This has been well-rewarded by the share price and a return to PER [price-earnings ratio] parity with INGR. Experience suggests that, when valuation returns to a more normal range, near-term earnings anxiety tends to prevail over longer-term re-rating aspiration. With FY19 guidance stretching, and a modestly below-consensus view, we return to the sidelines.”

Since its full-year results were released in May, Tate & Lyle has seen its share price rise around 10%, from around 609p on May 23 to 670p at last close on June 12.

In mid-morning trading Wednesday, Tate & Lyle shares were down 1.1% at 662p.

View full TATE profile View Profile

Tate & Lyle Timeline

Related Articles

April 17 2018
The group's major shareholders have staunchly supported the business while the AIM-listed group sorts out its financial position

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use